Merus Labs International Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
22
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
10
Merus Labs International General Information
Description
Operator of a specialty pharmaceutical company focused on acquiring and optimizing legacy growth products. The company is engaged in the acquisition and licensing of pharmaceutical products for women's health, cardiovascular health, urology and other infectious diseases.
Contact Information
Website
www.meruslabs.comCorporate Office
- 100 Wellington Street West
- Suite 2110
- Toronto, Ontario M5K 1H1
- Canada
Corporate Office
- 100 Wellington Street West
- Suite 2110
- Toronto, Ontario M5K 1H1
- Canada
Merus Labs International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Merus Labs International Comparisons
Industry
Financing
Details
Merus Labs International Competitors (13)
One of Merus Labs International’s 13 competitors is Knight Therapeutics, a Corporation company based in Montreal, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Knight Therapeutics | Corporation | Montreal, Canada | ||||
| AstraZeneca | Formerly PE-Backed | Cambridge, United Kingdom | ||||
| Novartis India | Corporation | Mumbai, India | ||||
| GSK | Corporation | Middlesex, United Kingdom | ||||
| Roche | Corporation | Basel, Switzerland |
Merus Labs International Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Merus Labs International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Merus Labs International Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Merus Labs International Investments & Acquisitions (10)
Merus Labs International’s most recent deal was a Corporate Asset Purchase with Sanofi (France Medicine unit) for . The deal was made on 23-Feb-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sanofi (France Medicine unit) | 23-Feb-2016 | Corporate Asset Purchase | Buildings and Property | ||
| UCB (Elantan, Isoket and Deponit Products) | 01-Feb-2016 | Corporate Asset Purchase | Buildings and Property | ||
| Novartis Pharma (Rights to Salagen and Estraderm MX) | 22-May-2015 | Corporate Asset Purchase | Buildings and Property | ||
| Novartis (Sintrom) | 08-Sep-2014 | Corporate Asset Purchase | Buildings and Property | ||
| Dacha Strategic Metals | 14-Aug-2014 | Merger/Acquisition | Other Metals, Minerals and Mining |
Merus Labs International Exits (1)
Merus Labs International’s most recent exit was on 30-Sep-2004 from John Street Advertising. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| John Street Advertising | 30-Sep-2004 | Completed |
|
Merus Labs International FAQs
-
When was Merus Labs International founded?
Merus Labs International was founded in 2011.
-
Where is Merus Labs International headquartered?
Merus Labs International is headquartered in Toronto, Canada.
-
What is the size of Merus Labs International?
Merus Labs International has 22 total employees.
-
What industry is Merus Labs International in?
Merus Labs International’s primary industry is Other Healthcare Services.
-
Is Merus Labs International a private or public company?
Merus Labs International is a Private company.
-
What is the current valuation of Merus Labs International?
The current valuation of Merus Labs International is .
-
What is Merus Labs International’s current revenue?
The current revenue for Merus Labs International is .
-
How much funding has Merus Labs International raised over time?
Merus Labs International has raised $102M.
-
Who are Merus Labs International’s investors?
Envoy Capital Group has invested in Merus Labs International.
-
Who are Merus Labs International’s competitors?
Knight Therapeutics, AstraZeneca, Novartis India, GSK, and Roche are some of the 13 competitors of Merus Labs International.
-
When was Merus Labs International acquired?
Merus Labs International was acquired on 17-Jul-2017.
-
Who acquired Merus Labs International?
Merus Labs International was acquired by Norgine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
